By Heidi Ledford – Nature
Researchers will discuss advances in genome-editing technologies — and the ethics of deploying them — at a major international summit.
When researchers gather in London next week for the Third International Summit on Human Genome Editing, they will discuss the latest advances in deploying to treat genetic diseases, and will look ahead to the possible approval of the first genome-editing therapy later this year. techniques such as CRISPR–Cas9
